000963:SHE
Huadong Medicine Co., Ltd.
CNÂ¥26.25
arrow_downward
-0.19%(-0.050) 1D
Oct 16, 3:04:24 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000963...
Open
CNÂ¥26.43
High
CNÂ¥26.90
Low
CNÂ¥25.98
Mkt. cap
46.61B
Avg. vol.
13.27M
Volume
15.87M
Dividend
3.54%
Quarterly dividend
CNÂ¥0.23
Ex-dividend date
Sep 18, 2026
P/E ratio
13.27
52-wk high
CNÂ¥43.78
52-wk low
CNÂ¥25.63
EPS
CNÂ¥1.98
Shares outstanding
1.75B
No. of employees
19K
Open
CNÂ¥26.43
High
CNÂ¥26.90
Low
CNÂ¥25.98
Mkt. cap
46.61B
Avg. vol.
13.27M
Volume
15.87M
Dividend
3.54%
Quarterly dividend
CNÂ¥0.23
Ex-dividend date
Sep 18, 2026
P/E ratio
13.27
52-wk high
CNÂ¥43.78
52-wk low
CNÂ¥25.63
EPS
CNÂ¥1.98
Shares outstanding
1.75B
No. of employees
19K
News stories
From web sources and news partners
marketscreener.com
·
1 hour ago
Health Care Down, But not by Much, Amid Defensive Bias -- Health Care Roundup
Yahoo Finance
·
2 hours ago
Skydance On Track To Be The Week's Worst-Performing S&P 500 Stock: Bernstein SocGen Halves Price Target On Cash Flow Uncertainty
ETF Database
·
11 minutes ago
S&P 500 Snapshot: Stocks Slide Nearly 2% for the Week
TradingView
·
2 hours ago
The Dow Jones Index Closes 0.34% Lower
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.
In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees19.1K
FoundedMar 31, 1993
Headquarters-
SectorHealth care provider
Websiteeastchinapharm.com